Testim and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Testim (testosterone) and Revlimid (lenalidomide). Common drug interactions include fatigue among females and neuropathy peripheral among males.

The phase IV clinical study analyzes what interactions people have when they take Testim and Revlimid. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Testim?

Testim has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 5,453 Testim users. Check the latest studies of Testim.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.



On Aug, 09, 2026

30 people who take Testim and Revlimid together, and have interactions are studied.

Testim and Revlimid drug interactions.

What are the common drug interactions of Testim and Revlimid, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Injury
  3. Tooth infection
  4. Abdominal pain
  5. Anaemia (lack of blood)
  6. Bone disorder
  7. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  8. Dehydration (dryness resulting from the removal of water)
  9. Depression
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Neuropathy peripheral (surface nerve damage)
  2. Fatigue (feeling of tiredness)
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Depression
  6. Erectile dysfunction
  7. Facet joint syndrome (problem with movement of the facet joints of the spine)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Intervertebral disc degeneration (spinal disc degeneration)
  10. Intervertebral disc protrusion (spinal disc protrusion)

What are the common drug interactions of Testim and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Osteonecrosis of jaw (death of bone of jaw)
  2. Pain
  3. Tooth infection
  4. Abdominal pain upper
  5. Anxiety
  6. Cholecystitis (infection of gallbladder)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Emotional distress
  9. Fatigue (feeling of tiredness)
  10. Gallbladder disorder

30-39:

n/a

40-49:

n/a

50-59:

  1. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  2. Depression
  3. Erectile dysfunction
  4. Facet joint syndrome (problem with movement of the facet joints of the spine)
  5. Intervertebral disc degeneration (spinal disc degeneration)
  6. Intervertebral disc protrusion (spinal disc protrusion)
  7. Neuropathy peripheral (surface nerve damage)
  8. Osteomyelitis (infection of bone)
  9. Osteonecrosis of jaw (death of bone of jaw)
  10. Pain

60+:

  1. Fatigue (feeling of tiredness)
  2. Neuropathy peripheral (surface nerve damage)
  3. Weight decreased
  4. Rash
  5. Tinea pedis (a contagious skin infection caused by the ringworm fungus)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Dehydration (dryness resulting from the removal of water)
  9. Migraine (headache)
  10. Night sweats (sweating in night)

What are the existing conditions these people have? *

  1. Seasonal Allergy (allergic condition due to certain season): 3 people, 10.00%
  2. Pain: 2 people, 6.67%
  3. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Testim and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Testim and Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Testim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Testim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Revlimid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on testosterone and lenalidomide (the active ingredients of Testim and Revlimid, respectively), and Testim and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: